Registration - Amendment
ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) for CARIS SCIENCE, INC.
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Precision medicine policies. Appropriate regulatory oversight of diagnostic testing. Coverage and reimbursement of Next Generation Sequencing and other technologies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE New | 99-01 Assistant to the Speaker for Policy; 03-05 Special Assistant to the President for Legislative Affairs |
Medicare/Medicaid MMM
Precision medicine policies. Appropriate regulatory oversight of diagnostic testing. Coverage and reimbursement of Next Generation Sequencing and other technologies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE New | 99-01 Assistant to the Speaker for Policy; 03-05 Special Assistant to the President for Legislative Affairs |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| CARIS LIFE SCIENCES, LTD | Cayman Islands | Cayman Islands | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.